journal article·2018-06

Revealing dye and dye-drug aggregation into nano-entities using NMR

Jayadeepa R. Murugesan, Fatma Shahout, Marwa Dlim, M. Michele Langella, Ernesto Cuadra-Foy, Pat Forgione, Steven R. LaPlante

Dyes and Pigments· Volume 153
Publisher page

Abstract

Abstract It is becoming increasingly apparent that small molecules can self-assemble into a wide-range of nano-entities in solution that have intriguing properties. The recently introduced NMR aggregation assay is playing an important role in revealing these nano-entities. Here, we employ the NMR aggregation assay to expose the self-aggregation tendencies of dyes in solution. This dilution-based assay demonstrates that some dyes can exist as single-molecule entities whereas others can adopt aggregates of distinct sizes. Interestingly, dyes with highly related chemical structures can adopt largely different sized aggregates - demonstrating the existence of structure-nanoentity relationships (SNR) – which suggests that they can assume and/or be designed to have distinct properties. One property was evaluated where the drug Quetiapine (Seroquel) was added to the dye Congo red which resulted in the absorption of the drug into the dye nano-entity. This showed a direct drug-dye interaction, and it demonstrated that dye aggregates can have influences on drug solution behaviors. The NMR method described in this study provides a practical and valuable tool to monitor dye aggregates and to better understand their associated properties (e.g. toxicity, off-target activity) and potential utility (e.g. drug encapsulation, drug delivery systems).
Source: openaire · Quality: candidate unverified · Source record ↗

Research context

OpenAlex topics: Molecular spectroscopy and chirality · Surfactants and Colloidal Systems · Analytical Chemistry and Chromatography

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (20)

Show source-provided references
1. Monitoring drug self-aggregation and potential for promiscuity in off-target in vitro pharmacology screens by a practical nmr strategy10.1021/jm4008714 ↗
2. Compound aggregation in drug discovery: implementing a practical NMR assay for medicinal chemists10.1021/jm400535b ↗
3. Stoichiometry and physical chemistry of promiscuous aggregate-based inhibitors10.1021/ja802977h ↗
4. https://chemaxon.com/.
5. A common mechanism underlying promiscuous inhibitors from virtual and high-throughput screening10.1021/jm010533y ↗
6. Aggregation of methylene blue in frozen aqueous solutions studied by absorption spectroscopy10.1021/jp050439j ↗
7. Aggregation of Congo red with surfactants and Ag-nanoparticles in an aqueous solution10.1016/j.saa.2015.11.015 ↗
8. Aggregation behaviour of two thiacarbocyanine dyes in aqueous solution10.1016/j.dyepig.2006.08.009 ↗
9. Minimization of self-quenching fluorescence on dyes conjugated to biomolecules with multiple labeling sites via asymmetrically charged NIR fluorophores10.1002/cmmi.1585 ↗
10. Aggregation behavior and chromonic liquid crystal properties of an anionic monoazo dye10.1103/PhysRevE.72.041710 ↗
11. Chromonic liquid crystal formation by edicol sunset yellow10.1021/jp802758m ↗
12. Molecular order in a chromonic liquid crystal: a molecular simulation study of the anionic azo dye sunset yellow10.1021/ja102468g ↗
13. A new sulfonated tetrazolium salt that produces a highly water-soluble formazan dye10.1248/cpb.41.1118 ↗
14. Medication dyes as a source of drug allergy
15. https://www.epa.gov/assessing-and-managing-chemicals-under-tsca/pigment-violet-29-anthra219-def6510-defdiisoquinoline-0.
16. Tau as a therapeutic target for Alzheimer's disease10.2174/156720511796717195 ↗
17. Concentration and pH dependent aggregation of hydrophobic drug molecules and relevance to oral bioavailability10.1021/jm049439i ↗
18. Colloidal aggregation affects the efficacy of anticancer drugs in cell culture10.1021/cb300189b ↗
19. https://www.food.gov.uk/science/additives/foodcolours.
20. https://www.ncbi.nlm.nih.gov/books/NBK304402/.